These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1661438)

  • 21. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of antithrombotic efficacy and haemorrhagic side-effects of Clivarin versus enoxaparin in patients undergoing total hip replacement surgery.
    Planes A
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S33-5; discussion S37-8. PubMed ID: 8180327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of postoperative thromboembolism in general surgery with enoxaparin.
    Samama MM
    Eur J Surg Suppl; 1994; (571):31-3. PubMed ID: 7519086
    [No Abstract]   [Full Text] [Related]  

  • 24. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
    Sureda A; García Frade LJ; Navarro JL
    Sangre (Barc); 1990 Oct; 35(5):389-96. PubMed ID: 1963241
    [No Abstract]   [Full Text] [Related]  

  • 26. Low molecular weight heparins and external pneumatic compression as options for venous thromboembolism prophylaxis: a surgeon's perspective.
    Caprini JA; Arcelus JI; Traverso CI; Hasty JH
    Semin Thromb Hemost; 1991 Oct; 17(4):356-66. PubMed ID: 1666456
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
    Breddin HK
    Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From prevention to therapy of thromboembolic processes: low-molecular heparin in body-weight adapted dosages].
    Internist (Berl); 1998 May; 39(5 Suppl Niedermole):1-16. PubMed ID: 9648001
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative study of 2 dosages of low molecular weight heparin, PK 10169, in the prevention of thromboembolic incidents during treatment of 103 femur neck fractures].
    Barsotti J; Dabo B; Andreu J; Favard L; Rosset P; Leroy J; Delahousse R; Alison D
    J Mal Vasc; 1987; 12 Suppl B():96-8. PubMed ID: 2834501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular-weight heparin-induced skin necrosis: a potential association with pre-existent hypercoagulable states.
    Toll A; Gallardo F; Abella ME; Fontcuberta J; Barranco C; Pujol RM
    Int J Dermatol; 2005 Nov; 44(11):964-6. PubMed ID: 16336536
    [No Abstract]   [Full Text] [Related]  

  • 33. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of thromboembolism in surgery].
    Reilmann H; Bosch U; Barthels M
    Orthopade; 1988 Feb; 17(1):110-7. PubMed ID: 2836777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
    Meurin P; Tabet JY
    Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
    [No Abstract]   [Full Text] [Related]  

  • 36. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboprophylaxis in the 1990s: a perspective.
    Fareed J
    Semin Thromb Hemost; 1991 Oct; 17(4):317-21. PubMed ID: 1666451
    [No Abstract]   [Full Text] [Related]  

  • 38. Subcutaneous low dose heparin in the prevention of postoperative thromboembolic complications.
    Kroese A; Dobloug I
    J Oslo City Hosp; 1976 Apr; 26(4):45-7. PubMed ID: 1263020
    [No Abstract]   [Full Text] [Related]  

  • 39. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.